Skip to content

Decamethonium

Drug profile

Also known as: decamethonium bromide, syncurine

OfmFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Decamethonium is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1975. DrugCentral lists 6 molecular targets, including CHRM2, HRH3 and Ache.

  • Approval status: ofm (first approved 1975 by the FDA).
  • Molecular targets: CHRM2, HRH3, Ache and Chrna4|Chrnb2 (6 listed in DrugCentral).
  • Molecular formula: C16H38N2; molecular weight 258.49 g/mol.

Mechanism & targets

Molecular targets (6)

TargetGeneActionActivity
Muscarinic acetylcholine receptor M2CHRM2unknownKi 7.60
Histamine H3 receptorHRH3unknownIC50 6.09
AcetylcholinesteraseAcheunknownKi 5.46
Neuronal acetylcholine receptor; alpha4/beta2Chrna4|Chrnb2unknownKi 5.24
AcetylcholinesteraseACHEunknownIC50 5.23
Muscle-type nicotinic acetylcholine receptorCHRNA1|CHRNG|CHRNB1|CHRNE|CHRNDpartial agonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1975-05-21FDA——

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Decamethonium is on its molecule page.

Molecular formulaC16H38N2
Molecular weight258.49 g/mol
CAS number156-74-1
InChIKeyMTCUAOILFDZKCO-UHFFFAOYSA-N
PubChem CID2968
C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Decamethonium work?

Its molecular targets in DrugCentral include CHRM2, HRH3, Ache and Chrna4|Chrnb2.

When was Decamethonium first approved?

Decamethonium was first approved by the FDA in 1975.

What is the chemical formula of Decamethonium?

Decamethonium has the molecular formula C16H38N2 and a molecular weight of 258.49 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1975-05-21
AgencyFDA
Targets6
Indications0
FormulaC16H38N2
DrugCentral ID789
Interactive profile